Professor Jane Kaye is Director of the Centre of Health, Law and Emerging Technologies (HeLEX) at the University of Oxford, which specialises in using methods of investigation and analysis from law, philosophy and the social sciences, and is committed to understanding and articulating the relationship between law, ethics, governance and best practice in health. She sits on a number of international expert committees and scientific advisory boards and is one of the leaders in the ELSI2.0 Initiative. Jane's research focuses on the role of law in the global regulation of innovative technologies in medicine, with a particular focus on biobanks and standardisation.
The University of Oxford
The University of Oxford has one of the largest Medical Sciences divisions in the world and is renowned for the excellence of its research and scholarship. Within the Medical Sciences division, the newly established Nuffield Department of Population Health is distinguished by its focus on inter-disciplinary research and capacity building. The Department hosts the Centre for Health, Law and Emerging Technologies (HeLEX) - one of the world’s leading centres in ELSI research investigating areas where new technologies are having a significant impact, such as the use of next generation sequencing technologies in the clinic and big data approaches to research.